What semi-targeted integration changes in biologics development
See how semi-targeted integration can improve cell line development, reduce clone screening, and support biologics development. Read the article.
India as a Global CRDMO Powerhouse: Debunking Quality Myths
Explore how India’s CRDMO quality systems, regulatory scrutiny, and biologics manufacturing capabilities challenge outdated quality myths. Read more.
Oligonucleotide Analytical Development: Five Hidden Traps and How to Avoid Them
Avoid five analytical traps in oligonucleotide development, from impurity profiling to bioanalysis and validation. Read more.